PMID- 1363892
OWN - NLM
STAT- MEDLINE
DCOM- 19930621
LR  - 20181130
IS  - 0369-8114 (Print)
IS  - 0369-8114 (Linking)
VI  - 40
IP  - 9 Pt 2
DP  - 1992 Dec
TI  - [Advances in lung cancer].
PG  - 956-9
AB  - Sessions about lung cancer of the 28th annual meeting of ASCO approached 
      especially non small cell lung cancer (NSCLC). Undoubtedly the outstanding facts 
      for this pathology was first the acknowledgment of the importance of a correct 
      staging system, in particular in stage IIIA for which resection is a prognostic 
      factor different for tumors T3N0, T3N1 as for N2. Two important topics have been 
      discussed on therapy: stage IIIA treatment, in particular neoadjuvant therapy 
      before surgery, and new drugs like Navelbine, taxol, and campthotecine which 
      suggest the possibility of improvements for chemotherapy of NSCLC in the next few 
      years. For small cell lung cancer (SCLC), different trials were designed to 
      improve dose intensity with growth factors, fractionation of therapy, autologous 
      bone marrow transplantation.
FAU - Pautier, P
AU  - Pautier P
AD  - Service d'Oncologie Moleculaire, Pavillon de Recherche n. 1, Institut Gustave 
      Roussy, Villejuif, France.
LA  - fre
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
TT  - Actualites dans le cancer bronchique.
PL  - France
TA  - Pathol Biol (Paris)
JT  - Pathologie-biologie
JID - 0265365
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Antineoplastic Agents, Phytogenic)
RN  - 5V9KLZ54CY (Vinblastine)
RN  - 7673326042 (Irinotecan)
RN  - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor)
RN  - P88XT4IS4D (Paclitaxel)
RN  - Q6C979R91Y (Vinorelbine)
RN  - XT3Z54Z28A (Camptothecin)
SB  - IM
MH  - Antineoplastic Agents/therapeutic use
MH  - Antineoplastic Agents, Phytogenic/therapeutic use
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Bone Marrow Transplantation
MH  - Camptothecin/analogs & derivatives/therapeutic use
MH  - Carcinoma, Non-Small-Cell Lung/*diagnosis/therapy
MH  - Carcinoma, Small Cell/*therapy
MH  - Combined Modality Therapy
MH  - Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use
MH  - Humans
MH  - Irinotecan
MH  - Lung Neoplasms/*diagnosis/therapy
MH  - Paclitaxel/therapeutic use
MH  - Vinblastine/*analogs & derivatives/therapeutic use
MH  - Vinorelbine
EDAT- 1992/12/01 00:00
MHDA- 1992/12/01 00:01
CRDT- 1992/12/01 00:00
PHST- 1992/12/01 00:00 [pubmed]
PHST- 1992/12/01 00:01 [medline]
PHST- 1992/12/01 00:00 [entrez]
PST - ppublish
SO  - Pathol Biol (Paris). 1992 Dec;40(9 Pt 2):956-9.